seeking business development and sales role opportunities
TRANSCRIPT
Currently Seeking Employment
Opportunities in business development
and sales
Contact Rafael Casiano at 813-330-
7555rafaelcasiano2@
gmail.com
Top Commercial performer in 2016Built a very strong funnel and generated $8M
in contracts in Year 2018 Increased the # of customers from 15 in 2015
to 40 in 2016Exceeded 2016 plan by $3MFinished 2016, 3x higher revenue than 2015 Increased the # of customers from 3 in 2014 to
15 in 2015Double sales in 2015 vs. 2014
Accelerate Discovery and Development from a Single Slide
5
Challenges in Diagnostics Discovery and Development
Limited patient tissue
for comprehensiv
e analysis
Implications• Rapid sample depletion
• Insufficient data for stratification research
• Therapeutic options limited for patients
Protein Biomarkers• Protein expression• Phosphorylation • Ligands / Growth factors• Cell types
Genomic Biomarkers• DNA• RNA• miRNA• Sequencing
Complex Disease Biology• Interactions of multiple
pathways• Tumor heterogeneity• Adaptive resistance
MultiOmyx enables comprehensive profiling, improved diagnosis, and therapeutic options.
Immunoprofiling-Hot Application for MultiOmyx
Immune classification color blends
CD4 CD8 CD68 PD-L1 pan-CK CD68|PD-L1
CD4 CD8 CD68 PD-L1 pan-CK
Immunofluorescence color blends
MultiOmyx enables profiling the types of immune cells present in the tumor
6
7
Serial Sections (5µm)
FFPE Block
(10-30 µm)
Single Ab staining
CD4CD8CD19CD45ROKi67
Different sections of a tissue being analyzed for different biomarkers may lead to different results!
Challenges with assessing immune markers co-expression in singleplexed assay
Co-expression Analysis
MO Multiplexed assay enables analysis of multiple immune markers co-expression from a single slide
8
Hyperplexed: stain, image, erase and repeat
Dye Inactivation>60
Proteins
PD-L1 PanCK
PD-L1 PanCK
9
CD8+ Ki67+
CD4+ CD45RO+ CD8+ CD45RO+
CD8+ Granzyme B+CD8+ PD1+
“Memory” T Helper “Memory” TC
“effector” TC“Proliferating” TC “Anergic” TC
Immune cell co-expressionCD4+FoxP3+ “Regulatory” T cell
Immune Cell Co-localization
PanCK CD3 CD4 CD8 FoxP3 PD-L1 CD68
Tumor/PanCK+
CD3+CD4+
T helper
CD3+CD4+FoxP3+
T regulatory
PD-L1+CD68+
CD3+CD8+
T cytotoxic
Tumor Margin
Innate (tumor cell intrinsic) resistance Adaptive resistance
12
VisualizationBiomarker overlays
Biomarker co-expression
• Visualize co-localization of markers
• Generate .png images for publications and presentations
• Evaluate biomarker co-expression
Biomarker heat maps
• Visualize heat maps of multiple biomarkers for assessment of expression and co-localization
Biomarker clusters
• Visualize results of cluster analysis and explore the biosignatures
Molecular H&E Molecular DAB
• Conversion of fluorescent image to a H&E appearance. Allows interpretation in context of tumor
• Conversion of fluorescent image to DAB appearance. Familiar format for pathologist
Cluster ID
Low Immune
Biomarker
Cell Count
s
Density in
Tumor (#/mm
2)
Density in
Stroma (#/mm
2)Tumor Cells 1386 NA NA
CD4+ 64 23.3 177.4CD8+ 47 11.7 134.6
CD20+ 13 7.8 33.6FOXP3+ 53 7.8 156.0PDL1+ 0 0 0
Biomarker
High Immune
Cell Count
s
Density in
Tumor (#/mm2
)
Density in
Stroma (#/mm2)
Tumor Cells 1692 NA NACD4+ 231 238.1 675.4CD8+ 299 492.3 547.0
CD20+ 14 2.7 61.8FOXP3+ 177 160.5 556.5PDL1+ 234 246.1 675.4
Hig
h Im
mun
eLo
w Im
mun
e
Multiplexed IF Analytics Output
CK CD4 CD8 CD20 FOXP3 PD-L1
CK CD4 CD8 CD20 FOXP3 PD-L1
CK CD4 CD8 CD20 FOXP3 PD-L1
CK CD4 CD8 CD20 FOXP3 PD-L1
13
Immune Infiltration
14
MultiOmyx Tumor Infiltrating Lymphocyte Panel
O Provides quantitative analytical results and spatial information of 12 cancer immune markers from every cell on a single FFPE
15
Dyes are cycled by a proprietary chemical inactivation methodGerdes et al (2013) PNAS
Multiplexed ProteinsProtein + DNA FISH
CD4 CD8 CD68 PD-L1 pan-CK
DNA Sequencing (ROI)Immune Phenotyping
- Up to 60 protein biomarkers can be fluorescently imaged in a single FFPE tissue section
- Additional “omics” such as RNAScope, DNA FISH, and NGS can be performed from the same IF processed slide and analyzed with protein data
- Advanced visualization of immune biomarker co-expression and co-localization
- Sophisticated algorithms identify individual cells and measure quantitative per-cell biomarker and morphology profiles
MultiOmyx Technology Summary…
17